Alkermes Plc (NASDAQ:ALKS)

41.47
Data as of Oct 01
 -1.40 / -3.27%
Today’s Change
29.36
Today|||52-Week Range
54.25
+1.99%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$6.3B

Company Description

Alkermes Plc is a biopharmaceutical company, which engages in the development, manufacturing and distribution of medicines. The company has a diversified portfolio of more than 20 commercial drug products and a substantial clinical pipeline of product candidates that address central nervous system disorders such as addiction, schizophrenia and depression. Alkermes was founded on May 4, 2011 and is headquartered in Dublin, Ireland.

Contact Information

Alkermes Plc
Connaught House
Dublin Dublin 4
P:(531) 772-8000
Investor Relations:

Employees

Shareholders

Mutual fund holders67.41%
Other institutional30.28%
Individual stakeholders0.77%

Top Executives

Richard F. PopsChairman & Chief Executive Officer
Shane M. CookePresident
Gordon G. PughSenior VP, Chief Operating & Risk Officer
James M. FratesChief Financial Officer, Treasurer & Senior VP
Elliot W. EhrichChief Medical Officer, SVP-Research & Development

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.